Placebo-controlled studies of antidepressants require a minimum level of severity on standardized measures such as the HAMD. The number of DSM-5 MDD symptom criteria met is significantly associated with HAMD scores. Thus, placebo-controlled studies of antidepressants require more DSM-IV/DSM-5 symptom criteria than are required for the diagnosis.